Dr Jonathan WadsleyDr Jonathan Wadsley MB, BChir, MA, MRCP, FRCR

Consultant Clinical Oncologist, Weston Park Hospital
Lead Clinician, North Trent Cancer Research Network
Tel: +44 (0) 114 226 5744
Fax: +44 (0) 114 226 5512
Email: jonathan.wadsley@sth.nhs.uk

As an NHS clinician my primary interest is in clinical research, with a particular focus on thyroid, upper GI, hepatobiliary and colorectal cancers. I am local principal investigator for a number of national trials in these areas, a member of the Trial Management Group of a number of these studies, and serve on the NCRI Upper GI Clinical Studies Group and Thyroid Subgroup.

As Clinical Lead for the North Trent Cancer Research Network I have responsibility for promoting cancer clinical trials wherever patients are being investigated for or receiving treatment for cancer across our Network.

Selected publications:

Radioiodine ablation (1.1 vs. 3.7GBq), with or without Thyrogen, for thyroid cancer. NEJM 2012

Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 2012

A randomised multicentre trial of epirubicin, oxaliplatin and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3). ASCO abstract 2012